drugset

drugset / Trial / NCT00150332

Linezolid for the Treatment of Infections Caused by Methicillin Resistant Staphylococcus Aureus in Japan

NCT00150332 ↗

Phase 3 Completed 24 enrolled Pfizer

Non-randomizedSingle-groupOpen-labelTreatment

Summary

Use of linezolid in patients with methicillin-resistant Staphylococcus aureus infections in Japan

Timeline

Start: 2003-01
Primary completion: —
Completion: 2006-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Linezolid	Other / unclassified	—	—

Indications